TD Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.82M | Buy |
|
|||||
|
2025
Q1 | $5.86M | Sell |
|
|||||
|
2024
Q4 | $11.7M | Buy |
|
|||||
|
2024
Q3 | $10.7M | Buy |
|
|||||
|
2024
Q2 | $9.18M | Sell |
|
|||||
|
2024
Q1 | $11M | Buy |
|
|||||
|
2023
Q4 | $6.28M | Buy |
|
|||||
|
2023
Q3 | $4.15M | Buy |
|
|||||
|
2023
Q2 | $1.06M | Buy |
|
|||||
|
2023
Q1 | $443K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $210K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $288K | Sell |
|
|||||
|
2018
Q3 | $313K | Buy |
|